At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics
In Brief
A clinical study evaluating ALL for Diabetes Mellitus and Cardiovascular Diseases. Completed, enrolled 4,856 participants.
Detailed Summary
The purpose of the ALL Study is to determine the effectiveness of the dissemination of the ALL intervention from an integrated care setting into Community Health Centers (CHCs) by measuring changes in diabetes mellitus (DM) population prescription rates for the medications, using a pre-post comparison within clinics and a staggered, randomized implementation across clinics.
Study Details
Timeline
Interventions
This clinic-level intervention involves a toolkit of decision support tools. These tools are listed below. 1. EHR tools to expedite identification a. EHR automated point-of-care alerts (Best Practice Alerts) 2. EHR tools to expedite prescribing 1. EHR order sets 2. EHR text shortcuts for notation 3. patient education materials (handout, poster) 3. EHR-based outreach support tools a. EHR registries
These clinics got the same exact intervention, but one year later, as this was a staggered randomized trial.